Abstract Details
|
Alissa A. Chitlangia, MD
(University of Alabama Medical Center)
PRESENTER |
Dr. Chitlangia has nothing to disclose. |
| Amelia K. Boehme, PhD (Columbia University) | Dr. Boehme has nothing to disclose. |
| Karen C. Albright, DO, DO, PhD, MS, MPH (FDA) | Dr. Albright has nothing to disclose. |
| Irene Litvan, MD, FAAN (UC San Diego Parkinson and Other Movement Disorder Center) | Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology. |
| Kara A. Sands, MD (University of Alabama at Birmingham, Department of Neurology) | Dr. Sands has nothing to disclose. |
| Harn Shiue, PharmD (Mayo Clinic Arizona Hospital) | Dr. Shiue has nothing to disclose. |
| No disclosure on file |